Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Qingping Cai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0001-7149-6723; OpenAlex author ID A5101769158. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper

Papers 3

  1. Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling. Last author DOI 10.1016/j.bbrc.2018.09.061↗
  2. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients. Co-author DOI 10.1007/s10620-017-4451-z↗
  3. Expression profiles analysis of pancreatic cancer. Last author PMID 23426533↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dejun Yang · 2 shared papers, 2017–2018 · strength 0.16
  2. Ziran Wei · 1 shared paper, 2017 · strength 0.07
  3. Ronglin Yan · 1 shared paper, 2017 · strength 0.07
  4. Yu Xin Zhang · 1 shared paper, 2017 · strength 0.07
  5. Dejun Yang · 1 shared paper, 2013 · strength 0.04
  6. Wei‐Jan Wang · 1 shared paper, 2013 · strength 0.04
  7. Chengfeng Wang · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.